BIONIK Laboratories Corp. Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Tables)

WARRANTS (Tables)

6 Months Ended

Sep. 30, 2017

Warrants and Rights Note Disclosure [Abstract]

Schedule Of Share Based Compensation Stock Purchase Warrants Activity [Table Text Block]

The following is a continuity schedule of the Company’s common share purchase warrants:

	Number of Warrants		Weighted-Average Exercise Price ($)
Outstanding and exercisable, March 31, 2015		10,823,450		1.35
Issued		7,225,625		1.35
Exercised		(148,787)		(0.80)
Outstanding and exercisable, March 31, 2016		17,900,288		1.35
Exercised		(262,045)		(0.80)
Outstanding and exercisable, March 31, 2017		17,638,243		1.35
Exercised		(5,000,172)		0.25
Dilution warrants issued to $0.80 warrant holders		83,752		0.749
Dilution warrants issued to $1.40 warrant holders		941,191		1.2933
Outstanding at September 30, 2017		13,663,014		1.241

Schedule of Common Share Purchase Warrants Outstanding [Table Text Block]

The following is a summary of common share purchase warrants outstanding after the warrant offer, the additional warrant issue and the re-pricing of the warrants as of September 30, 2017:

Exercise		Number of
Price ($)		Warrants		Expiry Date
	1.2933		5,873,289	February 26, 2019
	1.2933		1,229,040	March 27, 2019
	1.2933		328,166	March 31, 2019
	1.2933		2,544,240	April 21, 2019
	1.2933		1,201,164	May 27, 2019
	1.2933		1,173,370	June 30, 2019
	0.7490		1,313,745	February 26, 2019
			13,663,014